Quidel Q4 beat fails to lift shares, down 1% after hours

Quidel (NASDAQ:QDEL) Q4 results:

Revenue: $152.2M (+15%); cardiac immunoassay: $65.8M (+5%), influenza: $50.3M (+44%).

Net income: $30.6M (-6%); non-GAAP net income: $43.5M (+26%); EPS: $0.71 (-9%); non-GAAP EPS: $1.00 (+23%).

Consensus was non-GAAP EPS of $0.82 on revenues of $140M.

Quidel EPS beats by $0.18, beats on revenue

Shares down 1% after hours.

https://seekingalpha.com/news/3541352-quidel-q4-beat-fails-to-lift-shares-down-1-after-hours